bleomycin sulfate
Shortage expected
The supplier has told the TGA it expects this medicine to go into shortage. It has not necessarily done so yet. Your pharmacist can tell you what is in stock now.
The TGA has assessed this shortage as critical impact. That is a judgement about how hard the medicine is to substitute in clinical care, not a prediction about any one person. If you take this medicine, speak to your pharmacist or doctor about what is available. Do not stop or change how you take it on your own.
1 product record on the Australian Register of Therapeutic Goods, listed in full below. The TGA last updated this information on 31 August 2026. Not medical advice.
The TGA does not publish a reason for a shortage, so Voxsanity cannot show one. Nothing on this page is an explanation of why supply is affected — that information is not in the source and is not inferred here.
This is national information. The TGA records shortages for Australia as a whole. There is no state, territory or pharmacy-level stock information in this data, and Voxsanity cannot tell you whether a particular pharmacy has a medicine in stock. Your pharmacist can.
Products affected
DBL BLEOMYCIN 15000IU (as sulfate) powder for injection vial
Injection, powder for · ARTG 42569
Read the TGA's own shortage record for this product
- Status
- Shortage expected The supplier has told the TGA it expects this medicine to go into shortage. It has not necessarily done so yet. Your pharmacist can tell you what is in stock now.
- Supply
- Available The supplier reports stock is available, though not necessarily at every pharmacy.
- TGA impact rating
- Critical impact The TGA has assessed this shortage as critical impact. That is a judgement about how hard the medicine is to substitute in clinical care, not a prediction about any one person. If you take this medicine, speak to your pharmacist or doctor about what is available. Do not stop or change how you take it on your own.
- Reported from
- 1 January 2027 The TGA's dates span 18 months.
- Expected to be resolved
- 30 June 2028 This is the date the supplier has given the TGA. It can move.
- TGA last updated
- 31 August 2026
What the TGA says is being done
The sponsor is working to expedite the next shipment. An overseas-registered product has been approved for supply under Section 19A from 1 November 2026. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals
Quoted from the TGA's own record for this product. Voxsanity has not edited, summarised or interpreted it.
Terms like ARTG, TGA and PBS are explained in the glossary.
Where this comes from
Source: Medicine Shortage Reports Database, Therapeutic Goods Administration (TGA), © Commonwealth of Australia, reproduced with permission. The TGA does not endorse Voxsanity, and nothing here is presented as a TGA view. Shortage information is free for everyone on this site, with no account and no subscription.
Every product listed above links to the TGA's own shortage record for that product. The TGA's register is organised by product rather than by medicine, so there is no single TGA page covering bleomycin sulfate as a whole; to see them together, open the TGA Medicine Shortage Reports Database and type bleomycin sulfate into its filter box. General information about medicine shortages is on the TGA's medicine shortages page.
Voxsanity last read the register on 16 October 2026.
Not medical advice. Voxsanity republishes public government health data in plain English. Speak to your pharmacist or doctor about your own medicines. Do not stop or change how you take a medicine because of anything on this page.